Here's something you probably didn't expect to read today: some of the most promising science in the fight against obesity is coming from Burmese pythons.
Researchers from Stanford Medicine, the University of Colorado Boulder, and Baylor University have identified a molecule in python blood — called para-tyramine-O-sulfate (pTOS) — that may offer a new path to weight loss without the nausea and stomach upset that make GLP-1 drugs like Ozempic hard to tolerate for many people.
The findings were published in the journal Nature Metabolism on March 19, 2026.
Why Pythons?
Pythons have a superpower: they can swallow an entire deer, spend months fasting, and emerge from both experiences in perfect metabolic health. Their metabolism can ramp up 40-fold during digestion and then dial back down completely — without gaining dangerous fat or suffering organ damage.
Scientists have been studying python physiology for years, looking for clues to metabolic diseases in humans. This study found something unexpected lurking in their blood chemistry.
The Molecule That Changes Everything
After a big meal, levels of pTOS in python blood surge up to a thousandfold. When researchers gave pTOS to obese mice, the results were striking:
- Significant appetite suppression
- Measurable weight loss
- No gastrointestinal side effects — unlike GLP-1 drugs
The key difference from Ozempic-style drugs: pTOS appears to act on the hypothalamus (the brain's appetite control center), rather than primarily by slowing stomach emptying. That distinction may explain the cleaner side-effect profile.
And here's the really interesting part: humans already produce pTOS — just in much smaller amounts, and mainly after a large meal. It may already be part of our natural appetite signaling system. Pythons just have it dialled up to eleven.
What Happens Next
The researchers have formed a company called Arkana Therapeutics to commercialise these findings. Beyond weight loss, they're also investigating other metabolites in python blood that may address age-related muscle loss — a major challenge in ageing populations.
"This is nature-inspired biology at its best," said lead researcher Dr. Cecilia Riquelme. "Pythons solved problems millions of years ago that we're only beginning to understand."
With over 650 million people living with obesity worldwide, and a significant portion unable to tolerate current GLP-1 medications, a tolerable alternative could matter enormously. The snake, as it turns out, may have had the answer all along.
Source: Nature Metabolism, March 2026 | Stanford Medicine | University of Colorado Boulder | Baylor University
